A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects
Clinical trial NCT06948799 · RECRUITING
Trial details
- NCT number
- NCT06948799
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-08
- Primary completion
- 2026-07-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.